Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Facegenics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Facegenics

Facegenics

Seed

Facegenics: Innovating in medical technology for a healthier future.

HQ
Los Angeles, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Facegenics, a medical technology company, is dedicated to innovating for a healthier future. The company focuses on developing advanced medical treatments and technologies aimed at improving patient outcomes. Facegenics offers a range of products and services designed to enhance the capabilities of healthcare providers, including specialized training programs for physicians. Their market focus includes both healthcare professionals and institutions seeking cutting-edge medical solutions.

Notable affiliated individuals and investors include leading experts in medical technology and healthcare innovation, though specific names are not publicly detailed. Key achievements for Facegenics involve the successful development and implementation of their proprietary medical technologies, which have been adopted by numerous healthcare providers. The overall impact of Facegenics is significant, as their innovations contribute to more effective treatments and improved patient care across various medical fields.

Facegenics - Similar Companies

Aesthetics Biomedical logo

Aesthetics Biomedical

Genome Medical logo

Genome Medical

genomemedical.com

Geneicd logo

Geneicd

Equani logo

Equani

EndGenitor Technologies logo

EndGenitor Technologies

Genesis Medtech logo

Genesis Medtech

Genetica logo

Genetica

genetica.asia

Histogen logo

Histogen

histogen.com

Reveal HealthTech logo

Reveal HealthTech

Nexgen Medical Systems logo

Nexgen Medical Systems

GetDoctor logo

GetDoctor

getdoctor.co

GenHealth.ai logo

GenHealth.ai

genhealth.ai

Distinct Dermatology logo

Distinct Dermatology

GeniPhys logo

GeniPhys

geniphys.com

Ontogen Medtech logo

Ontogen Medtech

ontogenmedtech.com

Facegenics - Quick Facts

Who are Facegenics' competitors?

Companies similar to Facegenics include Aesthetics Biomedical, Genome Medical, Geneicd and Equani.

When was Facegenics founded?

Facegenics was founded in 2016.

Where is Facegenics' headquarters located?

Facegenics' headquarters is located in Los Angeles, CA, US.

When was Facegenics' last funding round?

Facegenics' most recent funding round was for $600k (USD) in January 2021.

How much has Facegenics raised to-date?

As of Jan 30, 2021, Facegenics has raised a total of $1.7M (USD).

How many employees does Facegenics have?

Facegenics has 5 employees as of Feb 4, 2024.

Facegenics - Classification

Industry
  • Professional Service Companies
Technology
  • HealthTech
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Medical Technology
  • Medical Treatments
Tags
  • Consulting
  • Healthcare
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified